awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37324772-815CFF99-626A-4B67-81D6-72AF7D20DD9F
Q37324772-815CFF99-626A-4B67-81D6-72AF7D20DD9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37324772-815CFF99-626A-4B67-81D6-72AF7D20DD9F
Drugs in early clinical development for Systemic Lupus Erythematosus.
P2860
Q37324772-815CFF99-626A-4B67-81D6-72AF7D20DD9F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37324772-815CFF99-626A-4B67-81D6-72AF7D20DD9F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
795206d6d63855c5ac07cdb5b0282aed97f4c37c
P2860
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).